Literature DB >> 3474823

Human erythrocyte antigens. III. Characterization of a panel of murine monoclonal antibodies that react with human erythrocyte and erythroid precursor membranes.

M J Telen, R M Scearce, B F Haynes.   

Abstract

Human erythrocyte membrane proteins express antigens which serve as markers for erythroid differentiation as well as targets for human blood group alloantibodies. We have produced and characterized a new panel of five monoclonal antibodies to erythrocyte membrane proteins. Three monoclonal antibodies (E3, E4, E5) were specific for erythrocyte glycophorins. One antibody (E3) identified the sialoglycoprotein alpha and beta homologous regions proximal to the plasma membrane, a second antibody (E4) was specific for sialoglycoprotein alpha, while a third (E5) was a sialoglycoprotein-beta-specific antibody. Two antibodies (E6 and TE10) to the 65,000-dalton chymotrypsin cleavage product of band 3 were also produced. These antibodies constitute a new panel of probes for investigation of normal erythroid differentiation, erythroleukemia, and the expression of normal and anomalous blood group antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3474823     DOI: 10.1111/j.1423-0410.1987.tb03035.x

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


  10 in total

1.  Erythrocyte plasma membrane-bound ERK1/2 activation promotes ICAM-4-mediated sickle red cell adhesion to endothelium.

Authors:  Rahima Zennadi; Erin J Whalen; Erik J Soderblom; Susan C Alexander; J Will Thompson; Laura G Dubois; M Arthur Moseley; Marilyn J Telen
Journal:  Blood       Date:  2011-12-06       Impact factor: 22.113

2.  Dr(a-) polymorphism of decay accelerating factor. Biochemical, functional, and molecular characterization and production of allele-specific transfectants.

Authors:  D M Lublin; E S Thompson; A M Green; C Levene; M J Telen
Journal:  J Clin Invest       Date:  1991-06       Impact factor: 14.808

3.  Miltenberger blood group antigen type III (Mi.III) enhances the expression of band 3.

Authors:  Kate Hsu; Naiwen Chi; Marjan Gucek; Jennifer E Van Eyk; Robert N Cole; Marie Lin; D Brian Foster
Journal:  Blood       Date:  2009-06-29       Impact factor: 22.113

4.  Immature human thymocytes can be driven to differentiate into nonlymphoid lineages by cytokines from thymic epithelial cells.

Authors:  J Kurtzberg; S M Denning; L M Nycum; K H Singer; B F Haynes
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

5.  Analysis of receptor for Vibrio cholerae El tor hemolysin with a monoclonal antibody that recognizes glycophorin B of human erythrocyte membrane.

Authors:  D Zhang; J Takahashi; T Seno; Y Tani; T Honda
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

6.  Biochemical characterization of the O-glycans on recombinant glycophorin A expressed in Chinese hamster ovary cells.

Authors:  P Påhlsson; D P Blackall; M Ugorski; M Czerwinski; S L Spitalnik
Journal:  Glycoconj J       Date:  1994-02       Impact factor: 2.916

7.  Protein area occupancy at the center of the red blood cell membrane.

Authors:  Allison D Dupuy; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

8.  In vitro and in vivo characterization of anthrax anti-protective antigen and anti-lethal factor monoclonal antibodies after passive transfer in a mouse lethal toxin challenge model to define correlates of immunity.

Authors:  Herman F Staats; S Munir Alam; Richard M Scearce; Shaun M Kirwan; Julia Xianzhi Zhang; William M Gwinn; Barton F Haynes
Journal:  Infect Immun       Date:  2007-08-20       Impact factor: 3.441

9.  Early events in human T cell ontogeny. Phenotypic characterization and immunohistologic localization of T cell precursors in early human fetal tissues.

Authors:  B F Haynes; M E Martin; H H Kay; J Kurtzberg
Journal:  J Exp Med       Date:  1988-09-01       Impact factor: 14.307

10.  Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.

Authors:  M J Telen; S E Hall; A M Green; J J Moulds; W F Rosse
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.